Target intelligence / Profile preview

Cellular and extracellular matrix environment (ECM)

Target
ECM
Molecular classification
Other
01

Overview

The cellular and extracellular matrix (ECM) environment is a complex, multi-component system consisting of an intricate network of extracellular macromolecules, such as collagen, glycoproteins, and proteoglycans, that provide structural and biochemical support to surrounding cells (NCI Dictionary, 2023). This environment serves as more than a passive scaffold; it actively regulates essential cellular processes including adhesion, migration, proliferation, and differentiation through mechanical and chemical signaling (Nature Reviews Molecular Cell Biology, 2014). In pathological states, the ECM environment undergoes significant remodeling; for instance, in cancer, a stiffened or altered matrix can promote tumor progression, epithelial-to-mesenchymal transition, and metastasis (Journal of Cell Science, 2020). While the environment as a whole is too broad to be considered a single therapeutic target, its individual constituents—such as integrin receptors, matrix metalloproteinases (MMPs), and specific collagen isoforms—are major focuses of drug development (PubMed, 2021). Targeting these components aims to disrupt the pro-disease microenvironment or restore tissue homeostasis, though significant challenges remain regarding the ubiquity of these proteins across healthy tissues and the potential for systemic side effects (StatPearls, 2023).

Other names
Extracellular matrixCellular microenvironmentMatrisomeInterstitial matrixBasement membrane
02

Mechanism of action

Modulation of cell-matrix interactions via integrin antagonism, inhibition of matrix-degrading enzymes (MMPs), or enzymatic degradation of specific matrix components like hyaluronan.

03

Biological functions

Structural supportCell signalingTissue homeostasisCell adhesionGrowth factor sequestrationMechanotransduction
04

Disease associations

CancerFibrosisOsteoarthritisCardiovascular diseaseGenetic disordersChronic inflammation
05

Safety considerations

Impaired wound healingSystemic toxicity due to ECM ubiquityMusculoskeletal syndromeOff-target effects on healthy tissue architectureRisk of opportunistic infections (e.g., PML with certain integrin inhibitors)
06

Interacting drugs

Vedolizumab

5 more in the full profile.

07

Biomarkers

Matrix metalloproteinase-9 (MMP-9)Collagen type I C-telopeptide (CTX-I)FibronectinHyaluronic acidLaminin

Beyond the preview

Go deeper on Cellular and extracellular matrix environment (ECM).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cellular and extracellular matrix environment (ECM).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call